Pharmacy Times July 18, 2022
Maker of Sensodyne, Advil, and TUMS becomes one of the world’s leading independent consumer health companies.
Today, Haleon (LSE/NYSE: HLN) launches as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed business is driven by its purpose todeliver better everyday health with humanity.
Trading commenced on Monday on the London Stock Exchange (LSE), with Brian McNamara, CEO of Haleon, leading the opening ceremony to signal the start of trading. Trading on the New York Stock Exchange (NYSE) is set to follow1 with a similar market-opening event taking place on Wednesday, July 20, 2022.
Haleon has a world-class portfolio of brands including Advil, Centrum, Sensodyne, Robitussin, and TUMS and will continue to develop category...
Today's Sponsors
Today's Sponsor